Get Your Free Audiobook
-
Hefty Price Set on a New Drug that can Stunt Muscle Disease
- Narrated by: Mike DelGaudio
- Length: 6 mins
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
New to Audible Prime Member exclusive: 2 credits with free trial
1 credit a month to use on any title to download and keep
Listen to anything from the Plus Catalogue—thousands of Audible Originals, podcasts and audiobooks
Download titles to your library and listen offline
₹199 per month after 30-day trial. Cancel anytime.
Hefty Price Set on a New Drug that can Stunt Muscle Disease
Narrated by:
Mike DelGaudio
Buy Now for ₹32.00
No valid payment method on file.
We are sorry. We are not allowed to sell this product with the selected payment method
Pay using card ending in
By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice.
Publisher's Summary
The Food and Drug Administration has approved the first drug to treat patients with spinal muscular atrophy, a savage disease that, in its most severe form, kills infants before they turn 2.
"Hefty Price Set on a New Drug that can Stunt Muscle Disease" is from the December 30, 2016 Financial section of The New York Times. It was written by Katie Thomas and narrated by Mike DelGaudio.
©2016 The New York Times News Service Division of The New York Times Company (P)2016 Audible, Inc.